Jerry W. Skiles - Concepedia

Author

Jerry W. Skiles

Boehringer Ingelheim (United States)

Also Known As

J W Skiles, J. Skiles, J. W. SKILES, J. W. Skiles, Jerry Skiles, Jerry W Skiles, Jerry W. Skiles, Skiles, J.W.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (United States)Novartis (Switzerland)

About

Jerry W. Skiles is an author at Boehringer Ingelheim (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	256
2	Biochemistry	6	6	184
3	Natural Sciences	5	5	166
4	Arts	1	1	21
5	Biomolecular Engineering	1	1	58

Jerry W. Skiles

Publications

814

Citations

H-Index

Page 1

	Year	Citations
A novel, dipyridodiazepinone inhibitor of HIV-1 reverse transcriptase acts through a nonsubstrate binding site Joseph C. Wu, Thomas C. Warren, Julian Adams, Biochemistry	1991	181
Spiro indolinone beta-lactams, inhibitors of poliovirus and rhinovlrus 3C-proteinases Jerry W. Skiles, Daniel W. McNeil Tetrahedron Letters Synthetic VirologyAntiviral Drug DevelopmentVirologyAntiviral DrugSpiro Indolinone Beta-lactams	1990	164
Asymmetric synthesis of cis-(−)-(2R4S)-4-(phosphonomethyl)-2-piperidinecarboxylic acid, a potent NMDA receptor antagonist Jerry W. Skiles, Peter P. Giannousis, Kevin R. Fales Bioorganic & Medicinal Chemistry Letters MedicineDrug DiscoveryAsymmetric SynthesisPharmacological AgentStereoselective Synthesis	1996	58
Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13 Lauren G. Monovich, Rubén Tommasi, Roger A. Fujimoto, Journal of Medicinal Chemistry Active Carboxylic AcidType Ii CollagenChemical BiologyOsteoporosisMusculoskeletal Research	2009	56
Angiotensin-converting enzyme inhibitors: new orally active 1,4-thiazepine-2,5-diones, 1,4-thiazine-2,5-diones, and 1,4-benzothiazepine-2,5-diones possessing antihypertensive activity Jerry W. Skiles, John T. Suh, Bruce Williams, Journal of Medicinal Chemistry	1986	53
Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones Jerry W. Skiles, Victor Fuchs, Clara K. Miao, Journal of Medicinal Chemistry	1992	48
elastase inhibitors containing conformationally restricted lactams as P3-P2 dipeptide replacements Jerry W. Skiles, Ronald Sorcek, Stephen P. Jacober, Bioorganic & Medicinal Chemistry Letters Elastase InhibitorsBiochemistryMedicineNatural SciencesRational Drug Design	1993	40
Angiotensin-converting enzyme inhibitors. New orally active antihypertensive (mercaptoalkanoyl)- and [(acylthio)alkanoyl]glycine derivatives John T. Suh, Jerry W. Skiles, Bruce Williams, Journal of Medicinal Chemistry HypertensionCardiovascular PharmacologyPharmacotherapyPharmaceutical ChemistryBlood Pressure	1985	34
Inhibition of human leukocyte elastase by N-substituted peptides containing .alpha.,.alpha.-difluorostatone residues at P1 Jerry W. Skiles, Clara K. Miao, Ronald Sorcek, Journal of Medicinal Chemistry	1992	27
Splendidine, a new oxoaporphine alkaloid from <i>Abuta</i><i>rufescens</i> Aublet Jerry W. Skiles, J. M. SAA, Michael P. Cava Canadian Journal of Chemistry Pharmaceutical ChemistryBioorganic ChemistryPharmacological StudyBiochemistryAntiparasitic Agent	1979	24

Page 1